Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextromethorphan probe study of tamoxifen pharmacokinetics in breast cancer
NL-OMON24889Not yet recruiting
- Sponsor
- Erasmus MC Cancer Institute
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tamoxifen and dextromethorphan in breast cancer, sponsored by Erasmus MC Cancer Institute. Planned start Jun 2009; status: not yet recruiting.
02
Drugs
tamoxifendextromethorphan
03
Conditions
breast cancer
Beyond the preview
Go deeper on NL-OMON24889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24889.